Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Tissue Repair: Protocol Comparison

Acute muscle strain 2mg twice weekly × 4 weeks 14–21 days to functional recovery Myofiber regeneration + reduced fibrosis Effective for grade 1–2 strains; grade 3 tears require surgical evaluation first Tendon injury (chronic tendinopathy) 2mg twice weekly × 6

This comparison does not assign a generated winner or score.

  • Acute muscle strain
  • 2mg twice weekly × 4 weeks
  • 14–21 days to functional recovery
  • Myofiber regeneration + reduced fibrosis
  • Effective for grade 1–2 strains; grade 3 tears require surgical evaluation first
  • Tendon injury (chronic tendinopathy)
  • 2mg twice weekly × 6–8 weeks
  • 4–6 weeks to measurable improvement
  • Collagen remodeling + angiogenesis into hypovascular tissue
  • Best combined with eccentric loading protocols; peptide alone insufficient
  • Cardiac tissue (research models)
  • 2–2.5mg twice weekly × 6 weeks
  • 3–6 weeks to reduced infarct size
  • Cardiomyocyte protection + border zone vascularization
  • Clinical use restricted to research settings; not approved for human cardiac therapy
  • Dermal wound healing
  • 1.5–2mg twice weekly × 3–4 weeks
  • 10–14 days to accelerated closure
  • Keratinocyte migration + granulation tissue formation
  • Effective for non-healing wounds; must rule out infection and vascular insufficiency
More references

Related material